急性心肌梗塞(AMI)是心内科常见的急症。在心肌梗塞早期(6小时以内)给予溶栓治疗,尤其是静脉尿激酶溶栓治疗,由于其疗效显著、副作用少,能有效地缩小梗塞面积,降低急性心肌梗塞的死亡率和改善患者的左室功能,已得到国内外越来越多学者的肯定,是近年来治疗AMI的重要进展之一。近几年来,我们对29例AMI患者应用尿激酶进行静脉溶栓治疗,取得了满意疗效,现报告如下: Acute myocardial infarction (AMI) is a common emergency in cardiology. Thrombolytic therapy, especially intravenous urokinase thrombolysis, in the early (within 6 hours) of myocardial infarction, is effective in reducing the infarct size, reducing the mortality of acute myocardial infarction and improving the left Room function, has been more and more scholars at home and abroad affirmed, is one of the important progress in the treatment of AMI in recent years. In recent years, 29 cases of AMI patients with urokinase intravenous thrombolytic therapy, and achieved satisfactory results, are as follows: